ONCIN — Oncoinvent ASA Cashflow Statement
0.000.00%
- NOK147.40m
- NOK147.18m
- NOK8.10m
Annual cashflow statement for Oncoinvent ASA, fiscal year end - December 31st, millions except per share.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | 12 M | 12 M | 12 M |
Source: | ARS | ARS | PRESS | ||
Standards: | — | — | IFRS | IFRS | — |
Status: | fx Preliminary | fx Preliminary | Final | Final | Final |
Net Income/Starting Line | — | — | -106 | -144 | -140 |
Depreciation | |||||
Non-Cash Items | — | — | -4.44 | -4.41 | -1.75 |
Other Non-Cash Items | |||||
Changes in Working Capital | — | — | 13.5 | -1.34 | 39.4 |
Change in Accounts Receivable | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | — | — | -89.2 | -138 | -87.9 |
Capital Expenditures | — | — | -3.98 | -26.8 | -1.8 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | — | 0 | 4.41 | 2.11 |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | — | — | -3.98 | -22.4 | 0.305 |
Financing Cash Flow Items | — | — | -0.094 | -0.342 | -12.7 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | — | — | -2.93 | -3.37 | 191 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | — | — | -96.1 | -164 | 104 |